+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
712313-35-4
Catalog No.:AA00FBG3

712313-35-4 | HAMI3379

This product is typically in stock,please click "Inquire" below or
contact us at [email protected] for pricing and availability information.
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00FBG3
Chemical Name:
HAMI3379
CAS Number:
712313-35-4
Molecular Formula:
C34H45NO8
Molecular Weight:
595.7230
SMILES:
OC(=O)C1CCCC(C1)NC(=O)c1cc(ccc1OCCCc1ccc(cc1)OCCCCOC1CCCCC1)C(=O)O
Properties
Computed Properties
 
Complexity:
853  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
43  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0  
Rotatable Bond Count:
16  
Undefined Atom Stereocenter Count:
2  
Undefined Bond Stereocenter Count:
0  
XLogP3:
6.2  

Literature

Title: Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats.

Journal: Brain research 20121112

Title: Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.

Journal: British journal of pharmacology 20100501

Title: Wunder F, et al. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor. Br J Pharmacol. 2010 May;160(2):399-409.

Title: Zhang XY, et al. HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation. J Pharmacol Exp Ther. 2013 Aug;346(2):328-41.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 712313-35-4
712313-33-2

712313-33-2
Building Blocks
More >
Tags:712313-35-4 Molecular Formula|712313-35-4 MDL|712313-35-4 SMILES|712313-35-4 HAMI3379
Catalog No.: AA00FBG3
712313-35-4
712313-35-4 | HAMI3379
This product is typically in stock,please click "Inquire" below or contact us at [email protected]for pricing and availability information.
Inquire
Technical Information
Catalog Number: AA00FBG3
Chemical Name: HAMI3379
CAS Number: 712313-35-4
Molecular Formula: C34H45NO8
Molecular Weight: 595.7230
SMILES: OC(=O)C1CCCC(C1)NC(=O)c1cc(ccc1OCCCc1ccc(cc1)OCCCCOC1CCCCC1)C(=O)O
Properties
Complexity: 853  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 43  
Hydrogen Bond Acceptor Count: 8  
Hydrogen Bond Donor Count: 3  
Isotope Atom Count: 0  
Rotatable Bond Count: 16  
Undefined Atom Stereocenter Count: 2  
Undefined Bond Stereocenter Count: 0  
XLogP3: 6.2  
Literature fold

Title: Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats.

Journal: Brain research20121112

Title: Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.

Journal: British journal of pharmacology20100501

Title: Wunder F, et al. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor. Br J Pharmacol. 2010 May;160(2):399-409.

Title: Zhang XY, et al. HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation. J Pharmacol Exp Ther. 2013 Aug;346(2):328-41.

Related Products of of 712313-35-4
712313-33-2
712313-33-2
Building Blocks More >
66966-38-9
66966-38-9
ETHYL PYRUVATE (3,3,3-D3)
AA00FBMB | MFCD00144295
669708-91-2
669708-91-2
4-Ethyl-5-[1-(4-ethylphenoxy)ethyl]-4h-1,2,4-triazole-3-thiol
AA00FBRR | MFCD04058188
723249-01-2
723249-01-2
ZLN-024
AA00FBZ6 | MFCD05155678
721418-09-3
721418-09-3
2-(4-Methoxy-3-(morpholinosulfonyl)phenyl)acetic acid
AA00FC3G | MFCD03950764
69221-14-3
69221-14-3
(1S,2R,4S,5R)-1-Benzyl-2-(hydroxy(quinolin-4-yl)methyl)-5-vinylquinuclidin-1-ium chloride
AA00FCAJ | MFCD00082423
683221-11-6
683221-11-6
3-Amino-3-(4-ethoxyphenyl)propan-1-ol
AA00FCL3 | MFCD03412722
66508-37-0
66508-37-0
FOSMIDOMYCIN, SODIUM SALT
AA00FCUT | MFCD27986862
731742-05-5
731742-05-5
2-(2-Bromoethyl)piperidine hydrobromide
AA00FD1M | MFCD08144834
667414-05-3
667414-05-3
2-(2,3-Dihydro-1h-inden-5-yloxy)-2-methylpropanoic acid
AA00FD64 | MFCD03422285
66147-29-3
66147-29-3
Methotrexate α-Methyl Ester
AA00FDAY | MFCD30720350
Submit
© 2017 AA BLOCKS, INC. All rights reserved.